Fortress Biotech Inc banner

Fortress Biotech Inc
NASDAQ:FBIO

Watchlist Manager
Fortress Biotech Inc Logo
Fortress Biotech Inc
NASDAQ:FBIO
Watchlist
Price: 3.7589 USD 14.95% Market Closed
Market Cap: $116.7m

Balance Sheet

Balance Sheet Decomposition
Fortress Biotech Inc

Balance Sheet
Fortress Biotech Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
2
15
23
40
100
50
98
88
95
66
137
233
306
178
81
57
Cash Equivalents
2
15
23
40
100
50
98
88
95
66
137
233
306
178
81
57
Short-Term Investments
0
0
0
0
0
20
0
2
36
18
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
0
0
9
8
8
14
25
24
28
15
10
Accounts Receivables
0
0
0
0
0
0
0
2
8
6
14
24
23
28
15
10
Other Receivables
0
0
0
0
0
0
0
7
1
2
1
1
1
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
1
1
1
10
14
10
14
Other Current Assets
0
0
0
0
1
1
2
10
44
20
4
7
7
10
11
8
Total Current Assets
2
15
23
41
100
71
100
110
183
111
156
266
347
230
117
90
PP&E Net
0
0
0
0
0
0
0
7
7
12
34
32
34
33
23
17
PP&E Gross
0
0
0
0
0
0
0
7
7
12
34
32
34
33
23
17
Accumulated Depreciation
0
0
0
0
0
0
0
0
1
3
5
7
9
12
9
12
Intangible Assets
0
0
0
0
0
0
1
17
1
1
7
15
13
27
20
32
Goodwill
0
0
0
0
0
0
0
19
0
0
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
0
4
3
1
1
0
11
18
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
15
15
16
53
16
18
3
3
4
7
5
Other Assets
0
0
0
0
0
0
0
19
0
0
0
0
0
0
0
0
Total Assets
2
N/A
15
+776%
23
+57%
41
+75%
101
+145%
89
-11%
119
+33%
171
+44%
246
+44%
141
-43%
226
+61%
333
+47%
397
+19%
294
-26%
168
-43%
144
-14%
Liabilities
Accounts Payable
1
1
1
1
1
0
2
24
28
34
23
29
67
77
53
48
Accrued Liabilities
2
1
3
2
5
4
8
12
1
1
16
19
25
23
23
20
Short-Term Debt
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
2
6
0
0
2
13
19
7
5
5
7
3
1
Other Current Liabilities
0
0
0
0
0
0
1
18
30
1
0
0
4
21
6
3
Total Current Liabilities
11
2
4
5
11
4
11
57
71
56
46
52
101
128
85
71
Long-Term Debt
1
0
1
12
7
14
23
26
49
60
82
60
47
93
61
58
Minority Interest
0
0
0
0
0
0
27
45
68
18
46
97
117
8
21
24
Other Liabilities
0
0
0
1
1
1
1
5
5
5
26
25
23
23
20
17
Total Liabilities
12
N/A
2
-86%
4
+163%
19
+352%
19
+2%
19
-3%
62
+229%
132
+114%
193
+46%
139
-28%
200
+44%
233
+16%
288
+23%
253
-12%
145
-43%
121
-16%
Equity
Common Stock
0
29
0
0
0
0
0
0
1
1
1
0
0
0
0
0
Retained Earnings
10
20
57
84
121
142
190
245
312
396
436
483
548
634
695
741
Additional Paid In Capital
0
4
76
106
203
212
247
284
364
397
462
583
656
676
717
764
Total Equity
10
N/A
13
N/A
19
+43%
22
+15%
81
+270%
71
-13%
57
-19%
39
-32%
53
+37%
2
-96%
26
+1 279%
100
+283%
109
+8%
42
-62%
23
-46%
23
+1%
Total Liabilities & Equity
2
N/A
15
+776%
23
+57%
41
+75%
101
+145%
89
-11%
119
+33%
171
+44%
246
+44%
141
-43%
226
+61%
333
+47%
397
+19%
294
-26%
168
-43%
144
-14%
Shares Outstanding
Common Shares Outstanding
1
1
1
2
3
3
3
3
3
4
5
6
7
7
15
28
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0
1
3
3
3
3
3